Followers | 53 |
Posts | 3489 |
Boards Moderated | 0 |
Alias Born | 02/05/2014 |
Tuesday, April 22, 2014 9:51:31 AM
We know what we know about the current lawsuit because much of it is public record, not confidential. You can look here:
http://www.lasuperiorcourt.org/civilcasesummarynet/ui/index.aspx?
Case Number:
BC427192
The very same guy who Chandana Basu slammed in last Friday's PR, grifter_24, was kind enough to purchase copies of the court documents and post them online for the rest of us:
Original PPJE v Grewal Civil Complaint
http://www.scribd.com/doc/200257910/PPJE-v-Grewal
Original Grewal v PPJE/Basu Cross-Complaint
http://www.scribd.com/doc/205067057/Grewal-Counter-Claim
If Chandana Basu would do what an effective CEO ought to be doing, and provide the shareholders with verifiable good news then the stock price would undoubtedly trade higher. Instead, we keep getting promises about how the company is growing because of business actions that we cannot verify from a company that has no audited finances. This is not uncommon in an OTC Pink, so perhaps we are all being a bit hard on PPJE compared to other stocks.
We thought this stock was a bit special because of the prospect of the huge probable gain in working capital we expected PPJ to receive from the lawsuit, but the trial has been delayed multiple already this year (not counting the years of delay previously). We were within days of the start of the trial the last couple of times, but it got delayed yet again.
Meanwhile, there has been a doubling of Authorized Shares (see the most recent amendment here: http://nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=mfueUqwrlF3DPmD5ebT8Gw%253d%253d&CorpName=PPJ+ENTERPRISE) to 2 billion. As I recall, the Outstanding Shares have tripled this year alone, and we know that PPJ is receiving $35,000 in funding every 10 days from a financier (http://ih.advfn.com/p.php?pid=nmona&article=61192974). So, are figuring that the funding is being paid for with dilution of stock value as huge numbers of shares get dumped into the market by the financier.
With regard to new business, there have been two big sets of announcements recently: one for a partnership with a clinic to operate a blood analyzer (http://ih.advfn.com/p.php?pid=nmona&article=60841163) and one for a new billing client (http://ih.advfn.com/p.php?pid=nmona&article=61694296).
It has been nearly 3 months since the blood analyzer partnership was announced, and we have heard zero since about actual execution of the plan, or any sort of results from the efforts.
There was an obvious cut-and-paste error regarding the new billing client (look at the recent PRs) and one iHub member tracked down that the PR was copied and modified from one issued 3 years ago. No one has anything against efficiency in work through the reuse of documents (in this case, a press release), but the editing to make it new was bungled so we all got a bit suspicious about its correctness. When grifter_24 tried to ask for more details on behalf of everyone here, he got slammed in last Friday's PR for his trouble.
So, why would the stock "just trade higher"?
Really... I'd love to have a reason because I'm holding a big pile of the stuff, and I'd really, really like it to trade higher, but without some verifiable good news, that is unlikely to happen.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM